Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02922556 · ClinicalTrials.gov registry record · NA
Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD)
A NA study, sponsored by Posit Science Corporation.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02922556 is a NA study that has completed, run by Posit Science Corporation. The registered enrollment target is 28 participants.
The verdict
NCT02922556, a NA study, has completed, sponsored by Posit Science Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
To assess the efficacy of a mobile-device-deployed cognitive emotional treatment for depression (Moodify) versus an active control treatment (commercially available computer games).
Interventions
- OTHER Computerized Plasticity-Based Adaptive Cognitive Training
- OTHER Commercially available computerized training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-06-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02922556
The ClinicalTrials.gov registry entry for NCT02922556 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Posit Science Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Computerized Plasticity-Based Adaptive Cognitive Training is the first listed.
NCT02922556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02922556 about?
NCT02922556 is a clinical study titled "Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD)". To assess the efficacy of a mobile-device-deployed cognitive emotional treatment for depression (Moodify) versus an active control treatment (commercially available computer games).
What is the current status of trial NCT02922556?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-09. Estimated completion is 2019-06-21.
What interventions are being tested in trial NCT02922556?
The interventions under investigation include: Computerized Plasticity-Based Adaptive Cognitive Training (OTHER), Commercially available computerized training (OTHER).
Who is sponsoring clinical trial NCT02922556?
This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.